Regen BioPharma (RGBPP) Loans and Notes Receivables (2016 - 2022)
Historic Loans and Notes Receivables for Regen BioPharma (RGBPP) over the last 5 years, with Q2 2022 value amounting to $5396.0.
- Regen BioPharma's Loans and Notes Receivables changed 0.0% to $5396.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $5396.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $5396.0 for FY2021, which is N/A changed from last year.
- According to the latest figures from Q2 2022, Regen BioPharma's Loans and Notes Receivables is $5396.0, which was down 0.0% from $5396.0 recorded in Q1 2022.
- Regen BioPharma's 5-year Loans and Notes Receivables high stood at $5396.0 for Q2 2021, and its period low was $4551.0 during Q1 2018.
- In the last 3 years, Regen BioPharma's Loans and Notes Receivables had a median value of $5396.0 in 2021 and averaged $5079.1.
- Data for Regen BioPharma's Loans and Notes Receivables shows a peak YoY increase of 0.0% (in 2018) and a maximum YoY decrease of 0.0% (in 2018) over the last 5 years.
- Regen BioPharma's Loans and Notes Receivables (Quarter) stood at $4551.0 in 2018, then rose by 18.57% to $5396.0 in 2021, then changed by 0.0% to $5396.0 in 2022.
- Its Loans and Notes Receivables stands at $5396.0 for Q2 2022, versus $5396.0 for Q1 2022 and $5396.0 for Q4 2021.